Back to Markets
RNCartesian Therapeutics Inc

Cartesian Therapeutics Inc

RNACNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$7.54

+0.3300 (+4.58%)

As of 05/29/26 EDT · USD

Compare
Low: $5.60Current: $7.54High: $15.57

Key Statistics

Open

$7.45

Day High

$7.60

Day Low

$6.90

Prev. Close

$7.21

VolumeShares traded today.

223.88K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$221.54M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-1.28

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$15.57

52W LowLowest price over the past 52 weeks.

$5.60

50D MAAverage closing price over the last 50 trading days.

$6.80

200D MAAverage closing price over the last 200 trading days.

$7.93

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+12.9%

1M

+16.5%

6M

+3.0%

YTD

+11.5%

1Y

-24.4%

About

Regenerative Medicine Advanced Therapy (RMAT) is a designation given by the Food and Drug Administration to drug candidates intended to treat serious or life-threatening conditions under the 21st Century Cures Act. A RMAT designation allows for accelerated approval based surrogate or intermediate endpoints.

www.cartesiantherapeutics.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade RNAC

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.